Cell & Gene Therapy Products 2023 Keynote Speaker: Becky Schweighardt, Grace Science LLC
Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series
Navigating regulatory challenges for cell and gene therapy products in 2024 and beyond
What’s Next for Cell and Gene Therapies in 2023 and Beyond
NecstGen Cell & Gene Therapy Journey-Collaboration across Analytical Development, QC & Manufacturing
The Dominance of Cell and Gene Therapy CDMOs in 2023- Market Trends and M&A Insights
Preclinical Considerations for Cell and Gene Therapy Products, an FDA Perspective
Cell and Gene Therapy Manufacturing Innovation
New Insights in Pharmacology: Highlights from the BJP and BJCP
Introducing the Cell and Gene Therapy Catapult’s Process Analytical Technologies Laboratory
A View On Manufacturing Cell and Gene Therapies
NecstGen Cell and Gene Therapy Journey - Role of Center of Excellence CDMO and perspective on QC
Cell and Gene Therapy Catapult ATMP GMP Manufacturing Report 2023
Cell & Gene Therapy Products 2022 Keynote: Peter Marks, CBER, FDA
Cell and Gene Therapy Supply Chain Challenges
2023 Industry Update at the Cell & Gene State of the Industry Briefing
Cell- and gene-therapy landscape in Parkinson’s disease
Cell Therapy Milestones in 2023
ASGCT: The Home of Cell and Gene Therapy
Cell and Gene Therapy: Advancing the Next Generation of Pharmaceuticals
